The new SMS-oncology Biometric Unit will deliver its services to pharmaceutical and biotech companies, allowing them to benefit from SMS-oncology’s therapeutic knowledge combined with a state of the art biometric unit in Budapest. The SMS-oncology Biometric Unit deploys eClinicalSuite, an Oracle based clinical data management system provided by OmniComm, supporting both paper based data collection (eDM) and Electronic Data Capture (EDC).

 

Wouter Wijker, the managing director of the SMS-oncology Biometric Unit: “Both our Clinical Data Management Systems (CDMS) and our internal IT environment have been designed to meet the regulatory requirements set forth by FDA 21 CFR Part 11 and FDA Guidance for Computerized Systems Used in Clinical Trials” .

 

“Our company is experiencing continuous growth. Opening a biometric office was the next logical step since we already service our clients with data management and statistical projects” says Eric van der Putten, CEO of SMS-oncology. “In addition, the office in Budapest is our first presence in Central and Eastern Europe”.

 

SMS-oncology is a Contract Research Organization (CRO) that contributes to the overall success of oncology product development by assisting pharma & biotech companies and Investigators with the design and full execution of clinical development and research programs. SMS-oncology is committed to sharing its oncology expertise with Sponsors and Investigators in the interest of fully uncovering the potential of new oncology products for daily practice. For more information, go to www.SMS-oncology.com.

 

Auxiliis Pharma is a CRO that offers a comprehensive package of research services for the pharmaceutical industry. Services for all therapeutic areas include protocol creation, CRF construction, medical review, data management, programming, statistical analysis, reporting and pharmacovigilance. For more information, go to www.Auxiliis-pharma.com.